PPARG and obesity disorder: Our results suggest that eicosapentaenoic and docosahexaenoic acids could be beneficial and effective against noncommunicable diseases, such as obesity, in people over 18 years old thanks to the anti-inflammatory role and the modulation of obesity-regulating genes such as PPARγ and those belonging to the ALOX family.